Company page

Immuron Limited

Immuron Limited, trading under the ticker IMC, is a public company based in Australia with a market capitalization of approximately AUD 8.98 million. The company focuses on developing innovative therapeutics and has a commitment to advancing its research and product pipeline. Immuron aims to address significant health challenges through its proprietary technologies.